Annual report
2667.TEDINET S100XAH7
Period2024-10-01 → 2025-09-30
Filed2025-12-23
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 13 passed
Key figures · 101
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥867m | 2024-10-01 → 2025-09-30 | Standalone | Net sales |
| Revenue | ¥1.6bn | 2023-10-01 → 2024-09-30 | Standalone | Net sales |
| Revenue | ¥3.0bn | 2022-10-01 → 2023-09-30v | Standalone | Net sales (5-year summary) |
| Revenue | ¥3.0bn | 2022-10-01 → 2023-09-30v | Standalone | Net sales (5-year summary) |
| Revenue | ¥3.3bn | 2021-10-01 → 2022-09-30v | Standalone | Net sales (5-year summary) |
| Revenue | ¥2.4bn | 2020-10-01 → 2021-09-30v | Standalone | Net sales (5-year summary) |
| Operating income | −¥410m | 2024-10-01 → 2025-09-30 | Standalone | Operating income |
| Operating income | −¥845m | 2023-10-01 → 2024-09-30 | Standalone | Operating income |
| Ordinary income | −¥448m | 2024-10-01 → 2025-09-30 | Standalone | Ordinary income |
| Ordinary income | −¥866m | 2023-10-01 → 2024-09-30 | Standalone | Ordinary income |
| Ordinary income | −¥710m | 2022-10-01 → 2023-09-30v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥690m | 2022-10-01 → 2023-09-30v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥359m | 2021-10-01 → 2022-09-30v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥319m | 2021-10-01 → 2022-09-30v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥413m | 2020-10-01 → 2021-09-30v | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | −¥555m | 2024-10-01 → 2025-09-30 | Standalone | Income before income taxes |
| Profit before tax | −¥885m | 2023-10-01 → 2024-09-30 | Standalone | Income before income taxes |
| Net income (owners) | −¥643m | 2022-10-01 → 2023-09-30v | Standalone | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥494m | 2021-10-01 → 2022-09-30v | Standalone | Profit loss attributable to owners of parent (5-year summary) |
| Net income | −¥559m | 2024-10-01 → 2025-09-30 | Standalone | Profit loss |
| Net income | −¥890m | 2023-10-01 → 2024-09-30 | Standalone | Profit loss |
| Net income | −¥659m | 2022-10-01 → 2023-09-30v | Standalone | Net income loss (5-year summary) |
| Net income | −¥483m | 2021-10-01 → 2022-09-30v | Standalone | Net income loss (5-year summary) |
| Net income | −¥513m | 2020-10-01 → 2021-09-30v | Standalone | Net income loss (5-year summary) |
| Total assets | ¥1.4bn | at 2025-09-30 | Standalone | Assets |
| Total assets | ¥1.6bn | at 2024-09-30 | Standalone | Assets |
| Total assets | ¥2.7bn | at 2023-09-30v | Standalone | Total assets (5-year summary) |
| Total assets | ¥2.7bn | at 2023-09-30v | Standalone | Total assets (5-year summary) |
| Total assets | ¥3.1bn | at 2022-09-30v | Standalone | Total assets (5-year summary) |
| Total assets | ¥3.1bn | at 2022-09-30v | Standalone | Total assets (5-year summary) |
| Total assets | ¥2.8bn | at 2021-09-30v | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥675m | at 2025-09-30 | Standalone | Liabilities |
| Total liabilities | ¥834m | at 2024-09-30 | Standalone | Liabilities |
| Net assets / equity | ¥718m | at 2025-09-30 | Standalone | Net assets |
| Net assets / equity | ¥736m | at 2024-09-30 | Standalone | Net assets |
| Net assets / equity | ¥1.6bn | at 2023-09-30v | Standalone | Net assets |
| Net assets / equity | ¥1.7bn | at 2023-09-30v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥2.3bn | at 2022-09-30v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥2.3bn | at 2022-09-30v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥2.5bn | at 2021-09-30v | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥563m | at 2025-09-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥554m | at 2024-09-30 | Standalone | Cash and deposits |
| Cash & equivalents | ¥563m | at 2025-09-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥554m | at 2024-09-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥823m | at 2023-09-30v | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥826m | at 2023-09-30v | Standalone | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥630m | at 2022-09-30v | Standalone | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥1.6bn | at 2021-09-30v | Standalone | Cash and cash equivalents (5-year summary) |
| Operating cash flow | −¥447m | 2024-10-01 → 2025-09-30 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | −¥207m | 2023-10-01 → 2024-09-30 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | ¥39m | 2022-10-01 → 2023-09-30v | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥318m | 2021-10-01 → 2022-09-30v | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥521m | 2020-10-01 → 2021-09-30v | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥61m | 2024-10-01 → 2025-09-30 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥25m | 2023-10-01 → 2024-09-30 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | ¥247m | 2022-10-01 → 2023-09-30v | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥984m | 2021-10-01 → 2022-09-30v | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥19m | 2020-10-01 → 2021-09-30v | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥517m | 2024-10-01 → 2025-09-30 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | −¥37m | 2023-10-01 → 2024-09-30 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | −¥91m | 2022-10-01 → 2023-09-30v | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥298m | 2021-10-01 → 2022-09-30v | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥1.2bn | 2020-10-01 → 2021-09-30v | Standalone | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥-50.46 | 2024-10-01 → 2025-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-82.92 | 2023-10-01 → 2024-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-59.98 | 2022-10-01 → 2023-09-30v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-61.43 | 2022-10-01 → 2023-09-30v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-48.12 | 2021-10-01 → 2022-09-30v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-47.09 | 2021-10-01 → 2022-09-30v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-56.43 | 2020-10-01 → 2021-09-30v | Standalone | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥52.56 | at 2025-09-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥68.56 | at 2024-09-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥151.9 | at 2023-09-30v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥151.44 | at 2023-09-30v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥211.88 | at 2022-09-30v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥212.87 | at 2022-09-30v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥240.52 | at 2021-09-30v | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 48.9% | at 2025-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 46.9% | at 2024-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 61.0% | at 2023-09-30v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 60.9% | at 2023-09-30v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.4% | at 2022-09-30v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.5% | at 2022-09-30v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 89.0% | at 2021-09-30v | Standalone | Equity to asset ratio (5-year summary) |
| ROE | -79.0% | 2024-10-01 → 2025-09-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | -75.4% | 2023-10-01 → 2024-09-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | -30.4% | 2022-10-01 → 2023-09-30v | Standalone | Rate of return on equity (5-year summary) |
| ROE | -31.1% | 2022-10-01 → 2023-09-30v | Standalone | Rate of return on equity (5-year summary) |
| ROE | -21.7% | 2021-10-01 → 2022-09-30v | Standalone | Rate of return on equity (5-year summary) |
| ROE | -19.6% | 2021-10-01 → 2022-09-30v | Standalone | Rate of return on equity (5-year summary) |
| ROE | -24.6% | 2020-10-01 → 2021-09-30v | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 13,035,700 | at 2025-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 10,803,600 | at 2024-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 10,803,600 | at 2023-09-30v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 10,803,600 | at 2022-09-30v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 10,303,600 | at 2021-09-30v | Standalone | Total number of issued shares (5-year summary) |
| Employees | 42 | at 2025-09-30 | Standalone | Number of employees |
| Employees | 43 | at 2024-09-30 | Standalone | Number of employees |
| Employees | 51 | at 2023-09-30v | Standalone | Number of employees |
| Employees | 48 | at 2022-09-30v | Standalone | Number of employees |
| Employees | 50 | at 2021-09-30v | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 45
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2024-10-01 → 2025-09-30 | ¥246,000 |
| Reconciling Itemsreconciling | segment assets | at 2025-09-30 | ¥865m |
| Reconciling Itemsreconciling | segment profit | 2024-10-01 → 2025-09-30 | −¥333m |
| Global Environment Solution Businessreportable segment | capex | 2024-10-01 → 2025-09-30 | ¥1m |
| Global Environment Solution Businessreportable segment | depreciation | 2024-10-01 → 2025-09-30 | ¥972,000 |
| Global Environment Solution Businessreportable segment | employees | at 2025-09-30 | 7 pure |
| Global Environment Solution Businessreportable segment | revenue | 2024-10-01 → 2025-09-30 | ¥209m |
| Global Environment Solution Businessreportable segment | revenue external | 2024-10-01 → 2025-09-30 | ¥209m |
| Global Environment Solution Businessreportable segment | segment assets | at 2025-09-30 | ¥407m |
| Global Environment Solution Businessreportable segment | segment profit | 2024-10-01 → 2025-09-30 | −¥14m |
| Healthcare Solutionreportable segment | capex | 2024-10-01 → 2025-09-30 | ¥11m |
| Healthcare Solutionreportable segment | depreciation | 2024-10-01 → 2025-09-30 | ¥4m |
| Healthcare Solutionreportable segment | employees | at 2025-09-30 | 24 pure |
| Healthcare Solutionreportable segment | revenue | 2024-10-01 → 2025-09-30 | ¥658m |
| Healthcare Solutionreportable segment | revenue external | 2024-10-01 → 2025-09-30 | ¥658m |
| Healthcare Solutionreportable segment | segment assets | at 2025-09-30 | ¥121m |
| Healthcare Solutionreportable segment | segment profit | 2024-10-01 → 2025-09-30 | −¥63m |
| —segment total | capex | 2024-10-01 → 2025-09-30 | ¥12m |
| —segment total | depreciation | 2024-10-01 → 2025-09-30 | ¥5m |
| —segment total | revenue | 2024-10-01 → 2025-09-30 | ¥867m |
| —segment total | revenue external | 2024-10-01 → 2025-09-30 | ¥867m |
| —segment total | segment assets | at 2025-09-30 | ¥528m |
| —segment total | segment profit | 2024-10-01 → 2025-09-30 | −¥77m |
| Reconciling Itemsreconciling | capex | 2023-10-01 → 2024-09-30 | ¥2m |
| Reconciling Itemsreconciling | depreciation | 2023-10-01 → 2024-09-30 | ¥6,000 |
| Reconciling Itemsreconciling | segment assets | at 2024-09-30 | ¥808m |
| Reconciling Itemsreconciling | segment profit | 2023-10-01 → 2024-09-30 | −¥382m |
| Global Environment Solution Businessreportable segment | capex | 2023-10-01 → 2024-09-30 | ¥4m |
| Global Environment Solution Businessreportable segment | depreciation | 2023-10-01 → 2024-09-30 | ¥2m |
| Global Environment Solution Businessreportable segment | revenue | 2023-10-01 → 2024-09-30 | ¥1.1bn |
| Global Environment Solution Businessreportable segment | revenue external | 2023-10-01 → 2024-09-30 | ¥1.1bn |
| Global Environment Solution Businessreportable segment | segment assets | at 2024-09-30 | ¥624m |
| Global Environment Solution Businessreportable segment | segment profit | 2023-10-01 → 2024-09-30 | −¥19m |
| Healthcare Solutionreportable segment | capex | 2023-10-01 → 2024-09-30 | ¥12m |
| Healthcare Solutionreportable segment | depreciation | 2023-10-01 → 2024-09-30 | ¥7m |
| Healthcare Solutionreportable segment | revenue | 2023-10-01 → 2024-09-30 | ¥482m |
| Healthcare Solutionreportable segment | revenue external | 2023-10-01 → 2024-09-30 | ¥482m |
| Healthcare Solutionreportable segment | segment assets | at 2024-09-30 | ¥138m |
| Healthcare Solutionreportable segment | segment profit | 2023-10-01 → 2024-09-30 | −¥444m |
| —segment total | capex | 2023-10-01 → 2024-09-30 | ¥16m |
| —segment total | depreciation | 2023-10-01 → 2024-09-30 | ¥9m |
| —segment total | revenue | 2023-10-01 → 2024-09-30 | ¥1.6bn |
| —segment total | revenue external | 2023-10-01 → 2024-09-30 | ¥1.6bn |
| —segment total | segment assets | at 2024-09-30 | ¥762m |
| —segment total | segment profit | 2023-10-01 → 2024-09-30 | −¥463m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,128
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of shares issued shares voting rights | CurrentYearInstant | 13035700 | |
| Number of voting rights issued shares voting rights | CurrentYearInstant | 129555 | |
| Number of shares held in own name treasury shares etc | CurrentYearInstant_Row1Member | 74500 | |
| Number of shares held in others names treasury shares etc | CurrentYearInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentYearInstant_Row1Member | 74500 | |
| Shareholding ratio treasury shares etc | CurrentYearInstant_Row1Member | 0.0057 | |
| Number of shares held in own name treasury shares etc | CurrentYearInstant | 74500 | |
| Number of shares held in others names treasury shares etc | CurrentYearInstant | － | |
| Total number of shares held treasury shares etc | CurrentYearInstant | 74500 | |
| Shareholding ratio treasury shares etc | CurrentYearInstant | 0.0057 | |
| Number of male directors and other officers | FilingDateInstant | 9 | |
| Number of female directors and other officers | FilingDateInstant | 0 | |
| Ratio of female directors and other officers | FilingDateInstant | 0.00 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02922-000KawakuraAyumuMember | 9606 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02922-000YokoyamaKeiichiMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02922-000TsudaYoshiyukiMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02922-000SuzukiMasashiMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02922-000MiyazakiKazuhikoMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02922-000HozuShouichiMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02922-000OotaniRyuseiMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02922-000SasakiTakeoMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02922-000TanakaNoriyukiMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant | 9606 | |
| Audit fees reporting company | Prior1YearDuration | 50000000 | JPY |
| Non audit fees reporting company | Prior1YearDuration | － | JPY |
| Audit fees reporting company | CurrentYearDuration | 35500000 | JPY |
| Non audit fees reporting company | CurrentYearDuration | － | JPY |
| Total amount of remuneration etc remuneration etc by category of directors and other officers | CurrentYearDuration_DirectorsExcludingAuditAndSupervisoryCommitteeMembersAndOutsideDirectorsMember | 35924000 | JPY |
| Fixed remuneration remuneration by category of directors and other officers | CurrentYearDuration_DirectorsExcludingAuditAndSupervisoryCommitteeMembersAndOutsideDirectorsMember | 35900000 | JPY |
| Performance based remuneration remuneration by category of directors and other officers | CurrentYearDuration_DirectorsExcludingAuditAndSupervisoryCommitteeMembersAndOutsideDirectorsMember | － | JPY |
| Non monetary remuneration remuneration by category of directors and other officers | CurrentYearDuration_DirectorsExcludingAuditAndSupervisoryCommitteeMembersAndOutsideDirectorsMember | 24000 | JPY |
| Retirement benefits remuneration etc by category of directors and other officers | CurrentYearDuration_DirectorsExcludingAuditAndSupervisoryCommitteeMembersAndOutsideDirectorsMember | － | JPY |
| Number of directors and other officers remuneration etc by category of directors and other officers | CurrentYearDuration_DirectorsExcludingAuditAndSupervisoryCommitteeMembersAndOutsideDirectorsMember | 4 | |
| Total amount of remuneration etc remuneration etc by category of directors and other officers | CurrentYearDuration_DirectorsAppointedAsAuditAndSupervisoryCommitteeMembersExcludingOutsideDirectorsMember | － | JPY |
| Fixed remuneration remuneration by category of directors and other officers | CurrentYearDuration_DirectorsAppointedAsAuditAndSupervisoryCommitteeMembersExcludingOutsideDirectorsMember | － | JPY |
| Performance based remuneration remuneration by category of directors and other officers | CurrentYearDuration_DirectorsAppointedAsAuditAndSupervisoryCommitteeMembersExcludingOutsideDirectorsMember | － | JPY |
| Non monetary remuneration remuneration by category of directors and other officers | CurrentYearDuration_DirectorsAppointedAsAuditAndSupervisoryCommitteeMembersExcludingOutsideDirectorsMember | － | JPY |
| Retirement benefits remuneration etc by category of directors and other officers | CurrentYearDuration_DirectorsAppointedAsAuditAndSupervisoryCommitteeMembersExcludingOutsideDirectorsMember | － | JPY |
| Number of directors and other officers remuneration etc by category of directors and other officers | CurrentYearDuration_DirectorsAppointedAsAuditAndSupervisoryCommitteeMembersExcludingOutsideDirectorsMember | － | |
| Total amount of remuneration etc remuneration etc by category of directors and other officers | CurrentYearDuration_OutsideDirectorsAndOtherOfficersMember | 15450000 | JPY |
| Fixed remuneration remuneration by category of directors and other officers | CurrentYearDuration_OutsideDirectorsAndOtherOfficersMember | 15450000 | JPY |
| Performance based remuneration remuneration by category of directors and other officers | CurrentYearDuration_OutsideDirectorsAndOtherOfficersMember | － | JPY |
| Non monetary remuneration remuneration by category of directors and other officers | CurrentYearDuration_OutsideDirectorsAndOtherOfficersMember | － | JPY |
| Retirement benefits remuneration etc by category of directors and other officers | CurrentYearDuration_OutsideDirectorsAndOtherOfficersMember | － | JPY |
| Number of directors and other officers remuneration etc by category of directors and other officers | CurrentYearDuration_OutsideDirectorsAndOtherOfficersMember | 6 | |
| Number of issues shares not listed investment shares held for purposes other than pure investment reporting company | CurrentYearInstant | 2 | |
| Carrying amount shares not listed investment shares held for purposes other than pure investment reporting company | CurrentYearInstant | 10000 | JPY |
| Number of issues shares other than those not listed investment shares held for purposes other than pure investment reporting company | CurrentYearInstant | － | |
| Carrying amount shares other than those not listed investment shares held for purposes other than pure investment reporting company | CurrentYearInstant | － | JPY |
| Number of issues whose number of shares increased shares not listed investment shares held for purposes other than pure investment reporting company | CurrentYearDuration | － |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 13 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | mismatch |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |